PUBLISHER: Grand View Research | PRODUCT CODE: 1908216
PUBLISHER: Grand View Research | PRODUCT CODE: 1908216
The global contrast media injectors market size was estimated at USD 2.24 billion in 2025 and is projected to reach USD 4.72 billion by 2033, growing at a CAGR of 9.52% from 2026 to 2033. The market is experiencing significant growth driven by the rising volume of CT, MRI, and interventional radiology procedures that require precise and consistent contrast delivery.
Growing incidences of chronic diseases and an ageing population further increase the need for advanced imaging, boosting injector adoption. In addition, technological innovations such as automated injectors, dose-tracking software, and syringeless systems enhance workflow efficiency and patient safety, encouraging hospitals to upgrade.
According to the data published by the CDC in February 2024, among 129 million adults in the U.S., roughly 52% live with at least one major chronic disease. Additionally, around 27% of adults, or approximately 68 million people, suffer from multiple chronic conditions, with higher rates observed among older adults and women.
The growing demand for advanced diagnostic imaging is a key driver of the contrast media injectors market. As the use of CT, MRI, ultrasound, and angiography procedures increases, healthcare providers require precise and efficient delivery of contrast agents to ensure high-quality imaging results. Rising cases of chronic diseases such as cancer, cardiovascular, and neurological disorders further contribute to the need for accurate diagnostic visualization. This growing reliance on advanced imaging technologies is accelerating the adoption of automated and high-performance contrast media injectors, which enhance diagnostic accuracy, workflow efficiency, and patient safety.
According to ScienceDirect, CT and ultrasound demonstrated gradual growth in their respective shares, with CT rising from 4.0% to 4.4% and ultrasound from 11.8% to 12.4%, while MRI usage remained relatively stable, increasing slightly from 5.3% to 5.4% from 2020 to 2023. The graph below shows the increasing trend of advanced imaging, reflecting the growing adoption of high-end diagnostic modalities in clinical practice.
Global Contrast Media Injectors Market Report Segmentation
This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global contrast media injectors market report on the basis of product, type, application, end use, and region: